As the U.S. stock market flirts with record highs, driven by a surge in AI-related stocks and strong earnings reports, investors are exploring opportunities beyond the major indices. Penny stocks, a term that might seem outdated but still relevant today, often represent smaller or newer companies that can offer unique investment potential. By focusing on those with robust financials and clear growth prospects, investors may uncover promising opportunities among these lesser-known equities.
|
Name |
Share Price |
Market Cap |
Financial Health Rating |
|
QuantaSing Group (NasdaqGM:QSG) |
$3.08 |
$110.92M |
★★★★★★ |
|
BAB (OTCPK:BABB) |
$0.87505 |
$6.41M |
★★★★★★ |
|
Kiora Pharmaceuticals (NasdaqCM:KPRX) |
$3.87 |
$12M |
★★★★★★ |
|
Inter & Co (NasdaqGS:INTR) |
$4.97 |
$2.09B |
★★★★☆☆ |
|
ZTEST Electronics (OTCPK:ZTST.F) |
$0.2896 |
$11.03M |
★★★★★★ |
|
Imperial Petroleum (NasdaqCM:IMPP) |
$2.925 |
$89.18M |
★★★★★★ |
|
Golden Growers Cooperative (OTCPK:GGRO.U) |
$4.50 |
$67.38M |
★★★★★★ |
|
BTCS (NasdaqCM:BTCS) |
$3.12 |
$59.16M |
★★★★★★ |
|
Smith Micro Software (NasdaqCM:SMSI) |
$1.28 |
$22.17M |
★★★★★☆ |
|
CBAK Energy Technology (NasdaqCM:CBAT) |
$0.9272 |
$82.51M |
★★★★★☆ |
Click here to see the full list of 709 stocks from our US Penny Stocks screener.
Let’s dive into some prime choices out of the screener.
Simply Wall St Financial Health Rating: ★★★★☆☆
Overview: Barfresh Food Group, Inc., along with its subsidiaries, operates in the United States by manufacturing and distributing ready-to-drink and ready-to-blend frozen beverages, with a market cap of $42.91 million.
Operations: The company’s revenue is generated from its non-alcoholic beverages segment, totaling $9.85 million.
Market Cap: $42.91M
Barfresh Food Group, Inc., with a market cap of US$42.91 million and revenue of US$9.85 million, has shown revenue growth but remains unprofitable, with a negative return on equity. The company reported third-quarter sales of US$3.64 million, an increase from the previous year, while its net loss slightly widened to US$0.513 million. Despite having more cash than total debt and reducing its debt-to-equity ratio significantly over five years, Barfresh faces challenges with less than a year of cash runway and high share price volatility. The management team is experienced, providing some stability amidst financial hurdles.
Simply Wall St Financial Health Rating: ★★★★★★
Overview: iCAD, Inc. provides cancer detection and therapy solutions in the United States and has a market cap of $56.13 million.